Diridavumab

Diridavumab
Monoclonal antibody
Type ?
Source Human
Target hemagglutinin
Clinical data
ATC code none
Identifiers
CAS Number 1393659-46-5
ChemSpider none
Chemical and physical data
Formula C6400H9934N1702O1996S48
Molar mass 144.2 kg/mol

Diridavumab[1] is a monoclonal antibody designed for the treatment of influenza A.[2]

This drug was developed by Janssen Pharmaceutical Companies of Johnson & Johnson.

References

  1. World Health Organization (2014). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 111" (PDF). WHO Drug Information. 28 (2).
  2. Statement On A Nonproprietary Name Adopted By The USAN Council - Diridavumab, American Medical Association.
This article is issued from Wikipedia - version of the 2/28/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.